Janux Therapeutics
1 follower
‌
Janux Therapeutics is developing safe, effective novel immunotherapies with the company’s proprietary TRACTr technology. Janux’s TRACTr technology employs a modular design to rapidly engineer drug candidates against specific targets.
Industries
Headquarters
Employees
Links
Org chart
David Campbell
Collapse
Tighe Reardon
Acting CFO
Andy Meyer
Chief Business Officer
Byron Robinson
Chief Strategy Officer
Carolina Caffaro
Executive Director, CMC
Hans Aerni
Senior Director, CMC Analytical Development
Jerry Warren
Senior Director Regulatory Affairs
Natalija Van Braeckel Budimir
Director, Immunology
Nick Almaguer
Director, Analytical Development
Sara Walsh
Executive Administrative Assistant to the President and Chief Executive Officer
Sheila Gujrathi, MD
Director Board Of Directors
Yogesh Bramhecha, PhD
Director, Biomarker Discovery
James Pennington
General Counsel
Koho Iizuka
VP, Clinical Development
Zachariah McIver
Vice President at Janux Therapeutics
Director, Human Resources
Vacant position
Tommy DiRaimondo
Executive Director, Research & Development
Megan Shannon
Senior Director, Clinical Science
Associate Director, Analytical Development
Vacant position
Associate Director, Quality Assurance
Vacant position
Human Resources Manager
Vacant position
Similar companies
REVOLUTION Medicines
5 followers
Halozyme Therapeutics
4 followers
Stemline Therapeutics
3 followers
Celularity
3 followers
Atomwise
3 followers
Pivot Bio
2 followers
Quantum-Si
2 followers
Arbutus Biopharma
2 followers
Keros Therapeutics
1 follower
Vividion Therapeutics
1 follower
Century Therapeutics
1 follower
Discover companies